ACADIA Pharmaceuticals Inc (ACAD) Stock Is Higher By 5.62% This Week: Buy, Hold, or Sell?

ACADIA Pharmaceuticals Inc (ACAD) stock is down -33.01% over the last 12 months, and the average rating from Wall Street analysts is a Buy. InvestorsObserver’s proprietary ranking system, gives ACAD stock a score of 30 out of a possible 100.

That rank is chiefly influenced by a short-term technical score of 23. ACAD's rank also includes a long-term technical score of 50.

ACAD has an Overall Score of 30. Find out what this means to you and get the rest of the rankings on ACAD!

See Full ACAD Report

What's Happening with ACAD Stock Today

ACADIA Pharmaceuticals Inc (ACAD) stock is up 2.64% while the S&P 500 is down -0.82% as of 1:52 PM on Tuesday, Jan 3. ACAD is higher by $0.42 from the previous closing price of $15.92 on volume of 436,274 shares. Over the past year the S&P 500 is lower by -20.61% while ACAD is down -33.01%. ACAD lost -$1.34 per share in the over the last 12 months. Click Here to get the full Stock Report for ACADIA Pharmaceuticals Inc stock.